Solid Biosciences Inc.
SLDB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001707502
No open-market purchases or sales by Solid Biosciences Inc. insiders were filed in the last 90 days; 157 institutions reported holding it in 13F filings for Q2 2026, worth $1.14B in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Solid Biosciences Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −3 vs. Q1 2023
- Shares held
- 16.3M
- +566.4K (+3.6%) vs. Q1 2023
- Total value
- $85.6M
- +$10.9M (+14.5%) vs. Q1 2023
- New holders
- 2
- 10 more added
- Sold out
- 5
- 7 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SLDB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 157 | $1.14B |
| Q1 2026 | 150 | $718.9M |
| Q4 2025 | 132 | $459.3M |
| Q3 2025 | 129 | $505.4M |
| Q2 2025 | 116 | $405.3M |
| Q1 2025 | 125 | $293.2M |
| Q4 2024 | 90 | $145.3M |
| Q3 2024 | 92 | $249.9M |
| Q2 2024 | 80 | $213.3M |
| Q1 2024 | 56 | $467.4M |
| Q4 2023 | 40 | $102.3M |
| Q3 2023 | 37 | $40.7M |
| Q2 2023 | 36 | $85.6M |
| Q1 2023 | 39 | $74.8M |
| Q4 2022 | 35 | $85.6M |
| Q3 2022 | 58 | $33.4M |
| Q2 2022 | 67 | $39.5M |
| Q1 2022 | 78 | $83.3M |
| Q4 2021 | 82 | $156.1M |
| Q3 2021 | 91 | $184.3M |
| Q2 2021 | 92 | $342.5M |
| Q1 2021 | 104 | $437.7M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Solid Biosciences Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Perceptive Advisors LLC | 3,495,933 | $18.3M | 0.53% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 3,426,286 | $18.0M | 0.34% | 00.0% | Unchanged |
| Bain Capital Life Sciences Investors, LLC | 3,130,422 | $16.4M | 1.69% | 00.0% | Unchanged |
| Camber Capital Management LP | 1,418,439 | $7.43M | 0.24% | 00.0% | Unchanged |
| Finepoint Capital LP | 961,251 | $5.04M | 1.74% | +472,394+96.6% | Added |
| Laurion Capital Management LP | 928,169 | $4.86M | 0.21% | 00.0% | Unchanged |
| Artal Group S.A. | 909,219 | $4.76M | 0.15% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 646,604 | $3.39M | 0.03% | 00.0% | Unchanged |
| Great Point Partners LLC | 584,458 | $3.06M | 0.61% | +374,053+177.8% | Added |
| Vanguard Group Inc | 248,042 | $1.30M | 0.00% | +25,345+11.4% | Added |
| BlackRock Inc. | 138,044 | $723.4K | 0.00% | −717−0.5% | Reduced |
| Caas Capital Management LP | 101,681 | $532.8K | 0.26% | −142,837−58.4% | Reduced |
| Walleye Capital LLC | 93,103 | $487.9K | 0.01% | +93,103 | New |
| Geode Capital Management, LLC | 89,259 | $467.7K | 0.00% | +47,348+113.0% | Added |
| Dimensional Fund Advisors LP | 62,164 | $325.7K | 0.00% | +5,829+10.3% | Added |
| Renaissance Technologies LLC | 27,670 | $145.0K | 0.00% | −11,093−28.6% | Reduced |
| Bridgeway Capital Management, LLC | 26,057 | $136.5K | 0.00% | −8,629−24.9% | Reduced |
| State Street Corp | 13,394 | $70.2K | 0.00% | 00.0% | Unchanged |
| CIBC Asset Management Inc | 12,083 | $63.3K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 11,434 | $59.9K | 0.00% | +372+3.4% | Added |
| Morgan Stanley | 4,618 | $24.2K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 4,417 | $23.1K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,326 | $12.2K | 0.00% | 00.0% | Unchanged |
| Lazard Asset Management LLC | 2,216 | $11.0K | 0.00% | +127+6.1% | Added |
| Royal Bank of Canada | 1,135 | $6.00K | 0.00% | +881+346.9% | Added |
| Manchester Capital Management LLC | 1,000 | $5.24K | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 214 | $1.12K | 0.00% | −60−21.9% | Reduced |
| UBS Group AG | 193 | $1.01K | 0.00% | +27+16.3% | Added |
| JPMorgan Chase & Co | 133 | $697 | 0.00% | 00.0% | Unchanged |
| First Manhattan Co | 133 | $696 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 125 | $655 | 0.00% | +2+1.6% | Added |
| Baker Avenue Asset Management, LP | 66 | $346 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 30 | $156 | 0.00% | −128−81.0% | Reduced |
| Rhumbline Advisers | 27 | $146 | 0.00% | +27 | New |
| Parallel Advisors, LLC | 6 | $31 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 1 | $5 | 0.00% | −299−99.7% | Reduced |
| Pura Vida Investments, LLC | 0 | $0 | 0.00% | −224,902−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −23,950−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −18,690−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −11,756−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |